192 related articles for article (PubMed ID: 31950781)
1. [Construction and Evaluation of a Tuberculosis Multistage Vaccine Candidate Based on Recombinant
Liu T; Liu SJ; Zhou YZ; Zhang YW; Wang C
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Jan; 51(1):1-6. PubMed ID: 31950781
[TBL] [Abstract][Full Text] [Related]
2. Intranasal vaccination with Listeria ivanovii as vector of Mycobacterium tuberculosis antigens promotes specific lung-localized cellular and humoral immune responses.
Jiang MJ; Liu SJ; Su L; Zhang X; Li YY; Tang T; Wang C
Sci Rep; 2020 Jan; 10(1):302. PubMed ID: 31942003
[TBL] [Abstract][Full Text] [Related]
3. [Construction and Evaluation of a Novel TB Vaccine Candidate Based on
Huang JL; Liu SJ; Su L; Wang C
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Nov; 48(6):814-818. PubMed ID: 29260512
[TBL] [Abstract][Full Text] [Related]
4. Heterologous Boosting With
Liu SJ; Tian SC; Zhang YW; Tang T; Zeng JM; Fan XY; Wang C
Front Immunol; 2020; 11():2036. PubMed ID: 32983151
[TBL] [Abstract][Full Text] [Related]
5. Construction of two Listeria ivanovii attenuated strains expressing Mycobacterium tuberculosis antigens for TB vaccine purposes.
Lin Q; Zhou M; Xu Z; Khanniche A; Shen H; Wang C
J Biotechnol; 2015 Feb; 196-197():20-6. PubMed ID: 25612873
[TBL] [Abstract][Full Text] [Related]
6. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.
Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X
PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536
[TBL] [Abstract][Full Text] [Related]
7. Highly persistent and effective prime/boost regimens against tuberculosis that use a multivalent modified vaccine virus Ankara-based tuberculosis vaccine with interleukin-15 as a molecular adjuvant.
Kolibab K; Yang A; Derrick SC; Waldmann TA; Perera LP; Morris SL
Clin Vaccine Immunol; 2010 May; 17(5):793-801. PubMed ID: 20357059
[TBL] [Abstract][Full Text] [Related]
8. A multistage-polyepitope vaccine protects against Mycobacterium tuberculosis infection in HLA-DR3 transgenic mice.
Geluk A; van den Eeden SJ; van Meijgaarden KE; Dijkman K; Franken KL; Ottenhoff TH
Vaccine; 2012 Dec; 30(52):7513-21. PubMed ID: 23103299
[TBL] [Abstract][Full Text] [Related]
9.
Jia Q; Masleša-Galić S; Nava S; Horwitz MA
mBio; 2022 Jun; 13(3):e0068722. PubMed ID: 35642945
[TBL] [Abstract][Full Text] [Related]
10. Protective Vaccine Efficacy of the Complete Form of PPE39 Protein from Mycobacterium tuberculosis Beijing/K Strain in Mice.
Kim A; Hur YG; Gu S; Cho SN
Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877927
[TBL] [Abstract][Full Text] [Related]
11. Construction and immunogenicity of the DNA vaccine of Mycobacterium Tuberculosis dormancy antigen rv1733c.
Zhang W; Jiang H; Bai YL; Kang J; Xu ZK; Wang LM
Scand J Immunol; 2014 May; 79(5):292-8. PubMed ID: 24498941
[TBL] [Abstract][Full Text] [Related]
12. Effects of the fusion design and immunization route on the immunogenicity of Ag85A-Mtb32 in adenoviral vectored tuberculosis vaccine.
Zhang Y; Feng L; Li L; Wang D; Li C; Sun C; Li P; Zheng X; Liu Y; Yang W; Niu X; Zhong N; Chen L
Hum Vaccin Immunother; 2015; 11(7):1803-13. PubMed ID: 26076321
[TBL] [Abstract][Full Text] [Related]
13. Development of a recombinant vaccine against foot and mouth disease utilizing mutant attenuated Listeria ivanovii strain as a live vector.
Mahdy SE; Sijing L; Lin S; Xiang Z; Hao-Tai C; Xiaofang P; Chuan W
J Virol Methods; 2019 Nov; 273():113722. PubMed ID: 31422118
[TBL] [Abstract][Full Text] [Related]
14. [Genetic Recombiniation and Protein Expression Detection of
Ren CY; Liu SJ; Pu QK; Jiang MJ; Zhou MY; Wang C
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 47(6):819-824. PubMed ID: 28598105
[TBL] [Abstract][Full Text] [Related]
15. [Immunoprophylaxis of recombinant Mycobacterium vaccae secreted MPT64 of Mycobacterium tuberculosis].
Bai YL; Xue Y; Wang LM; Fan AL; Zhang W; Kang J; He JJ; Xu ZK
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Mar; 25(3):211-4. PubMed ID: 19257983
[TBL] [Abstract][Full Text] [Related]
16. Performance of Homologous and Heterologous Prime-Boost Immunization Regimens of Recombinant Adenovirus and Modified Vaccinia Virus Ankara Expressing an Ag85B-TB10.4 Fusion Protein against
Kou Y; Wan M; Shi W; Liu J; Zhao Z; Xu Y; Wei W; Sun B; Gao F; Cai L; Jiang C
J Microbiol Biotechnol; 2018 Jun; 28(6):1022-1029. PubMed ID: 29847865
[TBL] [Abstract][Full Text] [Related]
17. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X
Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
[TBL] [Abstract][Full Text] [Related]
18. Mycobacterium tuberculosis multistage antigens confer comprehensive protection against pre- and post-exposure infections by driving Th1-type T cell immunity.
Ma J; Tian M; Fan X; Yu Q; Jing Y; Wang W; Li L; Zhou Z
Oncotarget; 2016 Sep; 7(39):63804-63815. PubMed ID: 27566581
[TBL] [Abstract][Full Text] [Related]
19. CpG7909 adjuvant enhanced immunogenicity efficacy in mice immunized with ESAT6-Ag85A fusion protein, but does not confer significant protection against Mycobacterium tuberculosis infection.
Hu S; Chen H; Ma J; Chen Q; Deng H; Gong F; Huang H; Shi C
J Appl Microbiol; 2013 Nov; 115(5):1203-11. PubMed ID: 23902541
[TBL] [Abstract][Full Text] [Related]
20.
Clemmensen HS; Dube JY; McIntosh F; Rosenkrands I; Jungersen G; Aagaard C; Andersen P; Behr MA; Mortensen R
mBio; 2021 Apr; 12(2):. PubMed ID: 33879592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
